The newly adopted two-part test introduced by the Department of Health and Human Services (HHS) focuses on two fundamental questions when determining whether a substance has an accepted medical use. First, it asks whether licensed healthcare providers currently use the substance in medical treatment within jurisdictions where such use is legally authorized. Second, it examines whether there is credible scientific evidence supporting the drug’s efficacy for at least one recognized medical condition.
High Times sent Ethan Zohn across the country during the World Cup to find where…
When most people think about the FIFA World Cup, they think about moments. The winning…
As younger consumers rethink their relationship with alcohol, retailers like SWADE Cannabis are betting cannabis…
Pepper’s drummer reflects on Point Break Festival, reggae-rock’s traveling family, growing up around Hawaiian cannabis,…
The hearing that could decide weed’s federal future starts June 29. The DEA invited seven…
Robinhood is a popular US-based investment app that allows everyday individuals to buy and sell…